These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 17442203)

  • 21. Non-surgical myocardial reduction in hypertrophic obstructive cardiomyopathy.
    Mutlak D; Gruberg L; Reisner S; Markiewicz W
    Isr Med Assoc J; 2002 Feb; 4(2):86-90. PubMed ID: 11875998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy; The Chinese experience in 119 patients from a single center.
    Li ZQ; Cheng TO; Zhang WW; Qiao SB; Zhao LY; Jin YZ; Guan RM; Liu L
    Int J Cardiol; 2004 Feb; 93(2-3):197-202. PubMed ID: 14975547
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Efficacy and safety of transthoracic echocardiography-guided percutaneous intramyocardial septal radiofrequency ablation for the treatment of patients with obstructive hypertrophic cardiomyopathy].
    Liu LW; Zuo L; Zhou MY; Li J; Zhou XD; He GB; Zhang J; Zhang JZ; Liu B; Yang J; Xu B
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Apr; 47(4):284-290. PubMed ID: 31060187
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparison of percutaneous transluminal septal myocardial ablation versus septal myectomy for the treatment of patients with hypertrophic obstructive cardiomyopathy--a meta analysis.
    Zeng Z; Wang F; Dou X; Zhang S; Pu J
    Int J Cardiol; 2006 Sep; 112(1):80-4. PubMed ID: 16507323
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The biphasic course of changes of left ventricular outflow gradient after alcohol septal ablation for hypertrophic obstructive cardiomyopathy.
    Veselka J; Duchonová R; Procházková S; Homolová I; Pálenícková J; Zemánek D; Pernisová Z; Tesar D
    Kardiol Pol; 2004 Feb; 60(2):133-6; discussion 137. PubMed ID: 15116158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ventricular evoked response in patients with hypertrophic obstructive cardiomyopathy treated with DDD pacing.
    Sant'Anna JR; Prati R; Hutten H; Schreier G; Kastner P; Kalil RA; Prates PR; Castro I; Azambuja PC; Faes F; Nesralla IA; Schaldach M
    Arq Bras Cardiol; 1999 Aug; 73(2):169-79. PubMed ID: 10752186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intracardiac echocardiography guidance during percutaneous transluminal septal myocardial ablation in patients with obstructive hypertrophic cardiomyopathy.
    Pedone C; Vijayakumar M; Ligthart JM; Valgimigli M; Biagini E; De Jong N; Serruys PW; Ten Cate FJ
    Int J Cardiovasc Intervent; 2005; 7(3):134-7. PubMed ID: 16243734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of Valsalva manoeuvre and exercise in echocardiographic evaluation of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy.
    Jensen MK; Havndrup O; Pecini R; Dalsgaard M; Hassager C; Helqvist S; Kelbæk H; Jørgensen E; Køber L; Bundgaard H
    Eur J Echocardiogr; 2010 Oct; 11(9):763-9. PubMed ID: 20472917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Non-drug treatment for hypertrophic obstructive cardiomyopathy in children].
    Zhang X; Li YF; Xie B; Chen JY; Qian MY
    Zhonghua Er Ke Za Zhi; 2011 May; 49(5):381-5. PubMed ID: 21624293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long term exercise capacity in patients with hypertrophic cardiomyopathy treated with percutaneous transluminal septal myocardial ablation.
    Malek LA; Chojnowska L; Klopotowski M; Maczynska R; Demkow M; Witkowski A; Kusmierczyk B; Piotrowicz E; Konka M; Dabrowski M; Ruzyllo W
    Eur J Heart Fail; 2008 Nov; 10(11):1123-6. PubMed ID: 18840395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ameliorating the severity of sleep-disordered breathing concomitant with heart failure status after percutaneous transluminal septal myocardial ablation for drug-refractory hypertrophic obstructive cardiomyopathy.
    Akita K; Maekawa Y; Kohno T; Tsuruta H; Murata M; Fukuda K
    Heart Vessels; 2017 Nov; 32(11):1320-1326. PubMed ID: 28555387
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of alcohol septal ablation for hypertrophic obstructive cardiomyopathy on Doppler Tei index: a midterm follow-up.
    Veselka J; Procházková S; Bolomová-Homolová I; Duchonová R; Tesar D
    Echocardiography; 2005 Feb; 22(2):105-9. PubMed ID: 15693775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Percutaneous transluminal septal myocardial ablation in drug-resistant hypertrophic obstructive cardiomyopathy: 18-month follow-up results.
    Oomman A; Ramachandran P; Subramanyan K; Kalarickal MS; Osman MN
    J Invasive Cardiol; 2001 Jul; 13(7):526-30. PubMed ID: 11435640
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimized pacing mode for hypertrophic cardiomyopathy: Impact of ECG fusion during pacing.
    Berruezo A; Penela D; Burgos F; Evertz R; Fernández-Armenta J; Roca J; Doltra A; Acosta J; Francino A; Sitges M; Alsina X; Ordoñez A; Villuendas R; Brugada R; Mont L; Brugada J
    Heart Rhythm; 2015 May; 12(5):909-16. PubMed ID: 25623178
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of successful alcohol septal ablation on microvascular function in patients with obstructive hypertrophic cardiomyopathy.
    Soliman OI; Geleijnse ML; Michels M; Dijkmans PA; Nemes A; van Dalen BM; Vletter WB; Serruys PW; ten Cate FJ
    Am J Cardiol; 2008 May; 101(9):1321-7. PubMed ID: 18435965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of right ventricular pacing site on left ventricular outflow tract obstruction in patients with hypertrophic obstructive cardiomyopathy.
    Gadler F; Linde C; Juhlin-Dannfeldt A; Ribeiro A; Rydén L
    J Am Coll Cardiol; 1996 Apr; 27(5):1219-24. PubMed ID: 8609346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Percutaneous transluminal septal myocardial ablation: a novel, nonsurgical treatment for symptomatic hypertrophic cardiomyopathy.
    Kar S; Makkar R
    Rev Cardiovasc Med; 2001; 2(2):97-102. PubMed ID: 12439386
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Computed tomography imaging to quantify the area of the endocardial subvalvular apparatus in hypertrophic cardiomyopathy - Relationship to outflow tract obstruction and symptoms.
    Tajima M; Iguchi N; Utanohara Y; Hiroi Y; Mahara K; Niwa T; Takayama M; Sumiyoshi T; Tomoike H
    J Cardiovasc Comput Tomogr; 2016; 10(5):351-8. PubMed ID: 27498132
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of dual-chamber pacing with nonsurgical septal reduction effect in patients with hypertrophic obstructive cardiomyopathy.
    Dimitrow PP; Podolec P; Grodecki J; Płazak W; Dudek D; Pieniazek P; Bacior B; Legutko J; Olszowska M; Kostkiewicz M; Kawecka-Jaszcz K; Tracz W; Dubiel JS
    Int J Cardiol; 2004 Mar; 94(1):31-4. PubMed ID: 14996471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Percutaneous transluminal septal myocardial ablation: past, present, and future.
    Maekawa Y; Takamisawa I; Takano H; Takayama M
    J Cardiol; 2022 Sep; 80(3):211-217. PubMed ID: 34924238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.